Verastem Oncology (VSTM) Tops Q3 EPS by 8c

Verastem Oncology (NASDAQ: VSTM) reported Q3 EPS of ($0.71), $0.08 better than the analyst estimate of ($0.79).

For earnings history and earnings-related data on Verastem Oncology (VSTM) click here.

You May Also Be Interested In

• Synopsys upgraded at Piper Sandler on Intel foundry momentum, Apple opportunity
• AMC Entertainment prices $200M stock offering to redeem senior notes
• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance